| Name | Title | Contact Details |
|---|
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
Blue Cross & Blue Shield of Mississippi (BCBSMS) is a Jackson, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Starr Regional Medical Center will be your trusted source online not only for your hospital information, but also for the time-saving, easy to use, in-depth healthcare information resource you`ll want to refer to frequently. Be active in your healthcare decisions, not a spectator. That`s why we give you access to millions of pages of the most credible, up-to-date medical information available. You can rely on such expert sources as The Merriam Webster Medical Dictionary.
Myomo Inc is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.